FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells
暂无分享,去创建一个
T. Matsumoto | Y. Shimada | Takayuki Yamada | Kazunori Saeki | S. Mima | H. Iwamura | C. Kakinuma | L. Paradiso | T. Higuchi | Hiroki Nishikawa | Nobuko Kito | H. Fujiwara | Rena Uematsu | Mikimasa Ishino | Hidenobu Kuniyoshi